Experimental Data Snapshot
Starting Model:experimental
View more details
(2005) Bioorg Med Chem Lett 15: 4345-4349
The SAR of a series of potent sulfonamide hydroxamate TACE inhibitors bearing a butynyloxy P1' group was explored. In particular, compound 5k has excellent in vitro potency against TACE enzyme and in cells, and oral activity in an in vivo model of TNF-alpha production and a collagen-induced arthritis model.
 Explore in 3D: Structure |Sequence Annotations |Electron Density |Validation Report |Ligand Interaction (IH6)
Biological assembly 1 assigned by authors.
 Explore in 3D: Structure |Sequence Annotations |Electron Density |Validation Report |Ligand Interaction (IH6)
Biological assembly 2 assigned by authors.
Macromolecule Content 
Entity ID: 1 | |||||
|---|---|---|---|---|---|
| Molecule | Chains | Sequence Length | Organism | Details | Image |
| ADAM 17 | 263 | Homo sapiens | Mutation(s): 2  Gene Names: ADAM17, CSVP, TACE EC: 3.4.24.86 | ![]() | |
UniProt & NIH Common Fund Data Resources | |||||
Find proteins for P78536 (Homo sapiens) Explore P78536  Go to UniProtKB:  P78536 | |||||
PHAROS:  P78536 GTEx:  ENSG00000151694  | |||||
Entity Groups  | |||||
| Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
| UniProt Group | P78536 | ||||
Sequence AnnotationsExpand | |||||
| |||||
| Ligands 2 Unique | |||||
|---|---|---|---|---|---|
| ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
| IH6 Query on IH6 Download Ideal Coordinates CCD File  | D [auth A], F [auth B] | (3S)-4-{[4-(BUT-2-YNYLOXY)PHENYL]SULFONYL}-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE C17 H22 N2 O5 S2 CVZIHNYAZLXRRS-HNNXBMFYSA-N | |||
| ZN Query on ZN Download Ideal Coordinates CCD File  | C [auth A], E [auth B] | ZINC ION Zn PTFCDOFLOPIGGS-UHFFFAOYSA-N | |||
| Length ( Å ) | Angle ( ˚ ) |
|---|---|
| a = 48.12 | α = 90 |
| b = 59.17 | β = 90 |
| c = 195.81 | γ = 90 |
| Software Name | Purpose |
|---|---|
| REFMAC | refinement |
| DENZO | data reduction |
| SCALEPACK | data scaling |
| AMoRE | phasing |
RCSB PDB Core Operations are funded by theU.S. National Science Foundation (DBI-2321666), theUS Department of Energy (DE-SC0019749), and theNational Cancer Institute,National Institute of Allergy and Infectious Diseases, andNational Institute of General Medical Sciences of theNational Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.